UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pediatric acute lymphoblastic leukemia presenting with periorbital edema

Otolaryngology case reports, 2018-11, Vol.9, p.11-14

2018

Volltextzugriff (PDF)

Challenges and opportunities in childhood cancer drug development

Nature reviews. Cancer, 2012-11, Vol.12 (11), p.776-782

2012

Volltextzugriff (PDF)

Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients

British journal of haematology, 2024-09, Vol.205 (3), p.1055-1066

2024

Volltextzugriff (PDF)

Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors

Pediatric blood & cancer, 2014-01, Vol.61 (1), p.145-150

2014

Volltextzugriff (PDF)

Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)

Pediatric blood & cancer, 2023-11, Vol.70 (11), p.e30609-e30609

2023

Volltextzugriff (PDF)

Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment

British journal of clinical pharmacology, 2016-09, Vol.82 (3), p.728-738

2016

Volltextzugriff (PDF)

Clinical trials: A plea to cooperative groups, consortia, pharmaceutical companies, and lead investigators for reasonable imaging protocols

Pediatric blood & cancer, 2023-10, Vol.70 (10), p.e30362-n/a

2023

Volltextzugriff (PDF)

Barriers to medication adherence among adolescents and young adults with cancer

Pediatric blood & cancer, 2023-03, Vol.70 (3), p.e30186-n/a

2023

Volltextzugriff (PDF)

Phase 1 trial of ontuxizumab (MORAb‐004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

Pediatric blood & cancer, 2018-05, Vol.65 (5), p.e26944-n/a

2018

Volltextzugriff (PDF)

Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short‐course EPOCH regimens are safe and effective

Pediatric blood & cancer, 2021-08, Vol.68 (8), p.e29126-n/a

2021

Volltextzugriff (PDF)

Feasibility pilot trial of a tailored medication adherence-promotion intervention for adolescents and young adults with cancer: Study design and protocol

Contemporary clinical trials, 2024-04, Vol.139, p.107483-107483, Article 107483

2024

Volltextzugriff (PDF)

Evaluating the role of phase I expansion cohorts in oncologic drug development

Investigational new drugs, 2017-02, Vol.35 (1), p.108-114

2017

Volltextzugriff (PDF)

Body Image Concerns in Adolescent and Young Adult Oncology Patients within Six Months of Upfront Diagnosis

Journal of adolescent and young adult oncology, 2024-10, Vol.13 (5), p.792-798

2024

Volltextzugriff (PDF)

Adherence and Barriers to Inpatient Physical Therapy Among Adolescents and Young Adults with Hematologic Malignancies

Journal of adolescent and young adult oncology, 2022-12, Vol.11 (6), p.605-610

2022

Volltextzugriff (PDF)

Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy

Leukemia, 2020-08, Vol.34 (8), p.2271-2275

2020

Volltextzugriff (PDF)

Abstract 2816: Evaluation of Cdk5 inhibitors in neural crest tumors

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2816-2816

2016

Volltextzugriff (PDF)

Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors

Pediatric blood & cancer, 2014-10, Vol.61 (10), p.1792-1797

2014

Volltextzugriff (PDF)

Location of Death and End-of-Life Characteristics of Young Adults with Cancer Treated at a Pediatric Hospital

Journal of adolescent and young adult oncology, 2019-08, Vol.8 (4), p.417-422

2019

Volltextzugriff (PDF)

The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL

Transplantation and cellular therapy, 2023-05, Vol.29 (5), p.311.e1-311.e7

2023

Volltextzugriff (PDF)

A liquid chromatography/tandem mass spectrometry method for determination of obatoclax in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014-11, Vol.971, p.30-34

2014

Volltextzugriff (PDF)

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma

Blood advances, 2023-07, Vol.7 (13), p.3225-3231

2023

Volltextzugriff (PDF)

Active and Protected: Developing a “Safer Sex” Handout for Adolescents and Young Adults with Cancer

Journal of adolescent and young adult oncology, 2021-06, Vol.10 (3), p.351-354

2021

Volltextzugriff (PDF)

Collaborating with Adolescents and Young Adults with Cancer as Advisors

Journal of adolescent and young adult oncology, 2018-08, Vol.7 (4), p.499-503

2018

Volltextzugriff (PDF)

Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias

Cancer chemotherapy and pharmacology, 2010-05, Vol.65 (6), p.1125-1130

2010

Volltextzugriff (PDF)

Evaluation of the retinoids with cisplatin and vincristine in xenograft models of neuroblastoma

Journal of pediatric hematology/oncology, 2014-01, Vol.36 (1), p.e23-e27

2014

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(55)

Publikationsform

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pediatric acute lymphoblastic leukemia presenting with periorbital edema

Challenges and opportunities in childhood cancer drug development

Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients

Preclinical evaluation of the PARP inhibitor, olaparib, in combination with cytotoxic chemotherapy in pediatric solid tumors

Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1)

Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment

Clinical trials: A plea to cooperative groups, consortia, pharmaceutical companies, and lead investigators for reasonable imaging protocols

Barriers to medication adherence among adolescents and young adults with cancer

Phase 1 trial of ontuxizumab (MORAb‐004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)

Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short‐course EPOCH regimens are safe and effective

Feasibility pilot trial of a tailored medication adherence-promotion intervention for adolescents and young adults with cancer: Study design and protocol

Evaluating the role of phase I expansion cohorts in oncologic drug development

Body Image Concerns in Adolescent and Young Adult Oncology Patients within Six Months of Upfront Diagnosis

Adherence and Barriers to Inpatient Physical Therapy Among Adolescents and Young Adults with Hematologic Malignancies

Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy

Abstract 2816: Evaluation of Cdk5 inhibitors in neural crest tumors

Phase 1 evaluation of EZN-2208, a polyethylene glycol conjugate of SN38, in children adolescents and young adults with relapsed or refractory solid tumors

Location of Death and End-of-Life Characteristics of Young Adults with Cancer Treated at a Pediatric Hospital

The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL

A liquid chromatography/tandem mass spectrometry method for determination of obatoclax in human plasma

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma

Active and Protected: Developing a “Safer Sex” Handout for Adolescents and Young Adults with Cancer

Collaborating with Adolescents and Young Adults with Cancer as Advisors

Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias

Evaluation of the retinoids with cisplatin and vincristine in xenograft models of neuroblastoma

Suchergebnisse filtern